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Background: Abnormal sleep behavior has been reported in 5 dogs during recovery from
tetanus.
Hypothesis: REM sleep behavior disorder (RBD) is a more common consequence of tetanus
than previously reported in veterinary literature and easily confused for epileptic seizures.
Animals: Sixty-one client-owned dogs diagnosed with tetanus at 2 UK referral centers.
Methods: A retrospective review of medical records was combined with a questionnaire sent to
owners of surviving dogs, to identify cases that developed clinically probable RBD and deter-
mine its clinical progression and effect on quality of life of affected dogs and their owners.
Descriptive statistical evaluation was performed.
Results: Eleven dogs (18%) died or were euthanized before discharge. At least 46% surviving
dogs developed abnormal “dream enactment” clinically consistent with RBD. Twitching, running,
and vocalization were new sleep behaviors in 53, 80, and 60% of affected dogs. Clinically proba-
ble RBD was described as violent or “nightmare”-like in 36% affected dogs, and like an epileptic
seizure in 40% affected dogs. When trialed, antiepileptic medications were ineffective. Onset
occurred before discharge in 25% cases. For dogs that developed clinically probable RBD post-
discharge, onset occurred within 2 weeks of discharge in 77% dogs. Clinically probable RBD did
not worsen in severity or frequency in any dog, and spontaneously resolved within 6 months in
43% cases.
Conclusions and Clinical Importance: Clinically probable RBD is a common sequel to canine tet-
anus with many clinical similarities to epileptic seizure activity. Owners should be made aware
of its potential development and care taken to avoid misdiagnosis with epileptic seizure activity.
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1 | INTRODUCTION
Tetanus is a disease that results from the irreversible binding of teta-
nospasmin toxin C (produced by the Gram-positive anaerobic spore-
forming bacillus Clostridium tetani) to presynaptic sites on inhibitory
neurons. This binding inhibits the release of the inhibitory neurotrans-
mitters glycine and γ-aminobutyric acid (GABA), resulting in sustained,
rigid contraction of muscles.1 In addition to muscular spasms, epileptic
seizure activity can also occur—likely because of the loss of inhibitory
function. Recovery from tetanus is dependent on the production of
new axonal terminals which can take weeks to months.2 Complete
resolution of epileptic seizure activity might occur, with discontinua-
tion of antiepileptic medication possible in these cases.3
There is limited published data in the veterinary literature, with
3 case series (of 13,3 20,4 and 385 dogs) and multiple single case
reports of tetanus in dogs. The case series have tended to focus on
risk factors for recovery and outcome with 23,5 also reporting on long-
Abbreviations: q12h, twice daily dosing; cpRBD, clinically probable REM sleep
behavior disorder.; CRI, continuous rate infusion.; EEG, electroencephalogra-
phy.; RBD, REM sleep behavior disorder.; REM, rpid eye movement.
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term outcome. In 1 case series, 3 (8%) dogs were reported to have
sleep-associated disorders at 6 and 12 weeks after recovery from tet-
anus, consisting of persistent muscular spasms that were hypothe-
sized to be the result of permanent damage to inhibitory
neurocircuits.5 No further information was provided regarding these
signs. Two case reports have also recorded post-tetanus sleep-
associated disorders.6,7 All dogs affected by these abnormal sleep
behaviors had exhibited generalized signs of tetanus.
Normal sleep comprises of a continuous cycle through 2 phases:
the initial nonrapid eye movement phase characterized by immobility
with retention of muscle tone, and the rapid eye movement (REM)
phase which is characterized by an alert state of brain activity, REM
and atony of the major limb muscles. While normal animals might dis-
play a degree of twitching and vocalization during REM sleep (com-
monly interpreted as manifestation of dream activity), loss of the
normal inhibition of select lower motor neuron ventral horn cells
results in violent limb movements and potentially aggressive behavior
during this phase of sleep. This abnormal and excessive manifestation
of dream activity is termed REM sleep behavior disorder (RBD).8–10 A
clinical diagnosis of RBD requires (1) repeated episodes of behavior or
vocalization that are either documented by polysomnography to arise
from REM or are presumed to arise from REM based on reported
dream enactment, and (2) evidence of REM sleep without atonia on
polysomnography.11 In cases where polysomnography is not per-
formed a provisional diagnosis (clinically probable RBD) can be made
if clinical findings are strongly suggestive.
We hypothesized that RBD is a more common consequence of
generalized tetanus than previously reported in the veterinary litera-
ture and can be confused for epileptic seizure activity. The primary
aim of this retrospective study was to further investigate the preva-
lence, clinical features, and severity of clinically probable RBD
(cpRBD) as a complication of tetanus. In addition, the study aimed to
determine whether this complication is truly permanent, whether anti-
epileptic medications (should these have been trialed) overtly reduced
the severity/frequency of episodes, and the effect of the disorder on
the quality of life of the dog and the owner.
2 | MATERIALS AND METHODS
This study was approved by the ethical committees of both participat-
ing institutions. Dogs with a presumptive diagnosis of tetanus pre-
senting between January 2000 and April 2017 were identified from
the databases of 2 UK veterinary referral centers. Cases were
included if their clinical signs (including risus sardonicus, erect ears,
protrusion of the third eyelids, trismus, and rigidity of multiple muscles
with worsening of clinical signs at times of stimulation), history and
clinical progression (progressive development of the above clinical
signs over days to weeks, with an identified potential source of infec-
tion deemed supportive) were consistent with tetanus, with diagnostic
investigations including comprehensive serum biochemistry profiles
and blood gas analyses excluding other causes of tetany (eg, second-
ary to hypocalcemia [total calcium <6.0 mg/dL {<1.5 mmol/L}; ionized
calcium <0.8 mmol/L], hypokalemia [<2.5 mEq/L {<2.5 mmol/L}], aci-
dosis [<7.20] and alkalosis [>7.55], and hypomagnesemia [<0.61 mg/
dL {<0.25 mmol/L}] where measured). Isolation of C. tetani from iden-
tified wounds was not necessary for inclusion of dogs in this study.
Data extracted from the medical records included signalment, his-
tory, information regarding clinical signs and their progression, treat-
ment, duration of hospitalization, whether a sleep disorder was noted
during the hospitalization period and if attempts were made to wake
the dog, whether electroencephalographic (EEG) recording was per-
formed during these episodes, and the presence/absence of epileptic
seizure activity during hospitalization. Questionnaires (see Supporting
Information) were subsequently sent to the owners of eligible survi-
vors to identify dogs that subsequently developed cpRBD, and to
evaluate the features, progression, response to treatment, and its
effect on the quality of life of both the dog and their owner. Sleep
behavior before the development of tetanus was also evaluated.
When available, video footage of the episodes was reviewed.
Descriptive statistical analysis (median, mean, SD, range) was per-
formed on data collected from medical records and the owner-
completed questionnaires.
3 | RESULTS
Sixty-one dogs met the inclusion criteria; 33 were male (20 entire,
13 neutered) and 28 were female (11 entire, 17 neutered). The
median age at presentation was 3.5 years (mean 3.78  2.77; range
0.25-10.4). Labradors were the most common breed (14/61; 23%),
followed by crossbreeds (12/61; 20%), Border Collies (4/61; 7%), Staf-
fordshire Bull Terriers (4/61; 7%), Cocker Spaniels (4/61; 7%), English
Springer Spaniels (3/61; 5%), Pointers (2; 3%), Dobermanns (2/61;
3%) and 1 each of Lurcher, Pug, Rhodesian Ridgeback, Munsterlander,
Weimaraner, Golden Retriever, American Bulldog, Scottish Terrier,
English Bull Terrier, Italian Spinone, Norfolk Terrier, and American
Cocker Spaniel. The median body weight at presentation was 22.2 kg
(mean 22.5  9.44; range 4.45-50).
Generalized signs of tetanus were evident in 55 dogs (90%)
whereas 6 (10%) displayed only focal (all involving only the muscles of
the head) tetanus throughout their illness. A wound or other source of
infection was identified in 58/61 (95%) dogs, with a total of 63 sites
of infection identified (2 dogs had 2 wounds, 1 dog had 3). The tho-
racic limbs were most commonly affected with 34/63 (54%) sites of
infection; digital wounds/nail bed infections were the most common
site (21/34; 62%). Twelve (19%) wounds were identified in the pelvic
limbs, with digital wounds/nail bed infections counting for half of
these. A further dog was reported to have a paw wound and a nail
bed infection however the affected limb was unclear from its records.
The affected digit(s) were radiographed in 23 dogs with digital
wounds/nail bed infections: 11/20 thoracic limb and 3/3 pelvic limb
digits exhibited radiographic evidence of osteomyelitis. Nine (14%)
wounds/sources of infection were identified in the oral cavity, with
6/9 (67%) associated with teeth. The remaining sites were the thorax
(1/63; 2%), abdomen (3/63; 5%—including 1 intra-abdominal [post-
ovariohysterectomy] case) and head (2/63; 3%). Clostridium species
were cultured from 4/12 (33%) cultured wounds. For 10 of these
cases, dogs were already receiving antibiotics at the time of culture,
including 2/4 dogs with clostridial growth. The median duration
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between identification of a wound/source of infection and onset of
clinical signs of tetanus was 12.4 days (mean 15.2  5.49;
range 0-30).
The median duration between onset of clinical signs to presenta-
tion at the referral hospital was 4.0 days (mean 4.6  4.10; range
0.5-30). All dogs were subsequently treated with appropriate antibi-
otic therapy (metronidazole, penicillin G, and/or doxycycline), analge-
sia and muscle relaxants. Tetanus antitoxin, wound debridement/digit
amputation and further supportive care (urinary catheterization, intra-
venous fluid therapy, feeding tube placement, gastrointestinal protec-
tants, physiotherapy, ocular and oral lubrication, suctioning of airways,
rotation of recumbency, oxygen supplementation, tracheostomy tube
placement, and mechanical ventilation) were administered as neces-
sary at the discretion of the primary clinician. Table 1 summarizes the
main targeted treatments: in addition, 4 dogs received continuous rate
infusions (CRI) of magnesium sulfate, 34 dogs received acepromazine,
28 dogs received a non-steroidal anti-inflammatory, 7 dogs received a
corticosteroid, 13 received an opioid, and 8 received another form of
analgesia (paracetamol, tramadol, gabapentin, lidocaine CRI). Propofol
and (dex)medetomidine CRIs were administered in 6 cases each; for
each treatment, 4 dogs were in the cpRBD group and 2 dogs died. An
in-dwelling urinary catheter was placed in 13 dogs; 9 dogs developed
cpRBD, 1 dog did not, and the remaining 3 dogs died. Mechanical ven-
tilation was required in 2 dogs; both subsequently died.
One dog was not hospitalized; for the remaining dogs, clinical
signs progressed during hospitalization in 27/60 (45%) dogs. Eleven
dogs (18%) died or were euthanized during hospitalization due to clini-
cal deterioration; 3 dogs were euthanized on the grounds of welfare,
2 were euthanized due to a combination of severe clinical deteriora-
tion and financial constraints, and 6 died of cardiopulmonary arrest
secondary to respiratory dysfunction (including respiratory tract
obstruction secondary to increased respiratory secretions and aspira-
tion). The median survival time from onset of clinical signs and admis-
sion to the referral practice were 7.5 (mean 6.9  3.04; range 2-11)
and 5.0 (mean 4.4  2.51; range 1-9) days, respectively. The median
duration of hospitalization for survivors was 9.0 days (mean 11  8;
range 0-30). Questionnaires were returned for 25 of the 50 surviving
dogs (50%) although not all questions were answered in every case.
Based on medical records alone (3 dogs) and combined medical
records and owner-completed questionnaires (20 dogs), a change in
sleep behavior was reported in 23 dogs (see Supporting Information).
All but 1 dog was affected by generalized tetanus. When attempted,
all dogs were easily woken from the episodes. Electroencephalo-
graphic recording during these episodes was not obtained in any dog,
however, based on overt dream enactment, ease of waking, a lack of
autonomic and post-ictal signs, and failure to respond to antiepileptic
medications when trialed, these episodes were considered consistent
with cpRBD.
Clinically probable RBD was first noted during hospitalization in
5/23 (22%) dogs, with the abnormal sleep behavior noted post-
discharge by their owners in the remaining 18/23 (78%) dogs. Only
5 dogs were reported to have never developed abnormal sleep behav-
ior; the presence/absence of cpRBD was unknown in 22 dogs. There-
fore, at least 23/50 (46%) dogs developed cpRBD during their
recovery from tetanus.
For dogs with onset after discharge, cpRBD reportedly occurred
during the first day/night after discharge (4/9; 44%), or within days
(1/9; 11%), 1 week (1/9; 11%), 1-2 weeks (1/9; 11%), <2 months (1/9;
11%), or >2 months (1/9; 11%) of discharge. Episodes consistent with
cpRBD occurred every time the dog slept in 5/18 (28%) cases, at least
once per day in 3/18 (17%) dogs, several times per week in 3/18
(17%) dogs, once a week in 2/18 (11%) dogs, several times per month
in 2/18 (11%) dogs, and once a month in 1/18 (6%) dogs. For the
remaining 2 dogs (11%), the owners were unsure of the frequency of
cpRBD.
Clinically probable RBD manifested as twitching (21/23; 91%),
running movements (19/23; 83%), vocalization (17/23; 74%), and jaw
chomping (8/17; 47%; refer to the Supporting Information). For the
dogs in which sleep behavior before the development of tetanus was
known, 5/16 (31%) dogs had never been seen to display any of these
movements and a further 10 (63%) dogs displayed new/different
sleep behaviors after tetanus. Twitching, running movements, and
vocalization manifested for the first time after tetanus in 8/15 (53%),
12/15 (80%) and 9/15 (60%) dogs, respectively. In dogs that had dis-
played running movements pre-tetanus, the degree of movement
increased in 7/9 (78%) dogs. While no dogs were themselves hurt
(although 1 was reported to have fallen from the sofa during cpRBD),
in 3/20 (15%) cases a human was bitten during an episode with 1 dog's
owner requiring hospitalization for bite wound treatment.
The severity of cpRBD was subjectively graded by owners as mild
in 7/19 (37%), moderate in 8/19 (42%), and severe in 4/19 (21%)
dogs. The episodes were described by owners or members of staff as
“violent” or a “nightmare” in 7/20 (35%) dogs, and like an epileptic sei-
zure in 8/20 (40%) dogs. Despite 12/19 (63%) owners subjectively
considering the cpRBD to be moderate or severe, only 1/19 (5%),
4/19 (21%), and 1/19 (5%) owners felt they needed to wake their dog
from these episodes quite often, very often or every time, respec-
tively. The owners of 8/19 (42%) never woke their dog, with the
remaining owners only occasionally feeling they needed to wake their
pet. On waking, 11/16 (69%) dogs were reported to be normal and
5/16 (31%) dogs initially appeared disorientated or confused.
For 14/17 (82%) dogs, the cpRBD had no perceivable impact on
their quality of life according to their owner. Quality of life was sub-
jectively considered minimally and mildly impaired in 1/17 and 2/17
dogs, respectively, with no dog perceived to have a moderately or
markedly worse quality of life. While 14/16 (88%) and 1/16 owners
felt their own quality of life was not or minimally impaired, 1/16
owners reported a marked impact on their own quality of life as a
result of their dog's cpRBD.
The frequency of the cpRBD improved in 9/17 (53%) dogs.
Where it was known, this improvement occurred within 1-2 weeks in
3/6 (50%) dogs and within 6 months for the remaining 3. The severity
of cpRBD episodes improved in 8/15 (53%) dogs. In the cases for
which it was known, this improvement occurred within 1-2 weeks or
1-2 months in 2/5 (40%) dogs each. In the remaining dog, improve-
ment in episode severity was noted between 2 and 6 months after
onset. The cpRBD episodes resolved in 7/16 (44%) dogs, with a return
to normal sleep behavior within 1-2 weeks (1/6; 17%), within 1 month
(2/6; 33%), between 1 and 2 months (1/6; 17%) or between 2 and
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TABLE 1 The main targeted treatments administered to dogs with tetanus (n indicates the number of dogs that received the treatment; days post-onset refers to the number of days after the onset of
clinical signs of tetanus that the treatment was performed)
Treatment administered
Dogs with cpRBD Dogs without cpRBD Nonsurvivors All survivors
Median Mean (SD) Range (n) Median Mean (SD) Range (n) Median Mean (SD) Range (n) Median Mean (SD) Range (n)
Antibiotics (days administered)
Metronidazole 27.5 22.8 (8.2) 10-32 (22) 31.5 42.3 (38.5) 12-94 (5) 6.5 6.3 (3.0) 2-10 (7) 18 22 (16.1) 8-94 (49)
Amoxicillin-clavulanic acid 22 20.1 (9.0) 7-32 (14) 37 43.0 (34.0) 10-88 (5) 1.5 3.5 (3.7) 1-10 (8) 22 22.3 (18.2) 4-88 (29)
Penicillin G 5.5 5.5 (6.1) 1-10 (2) 0 0 0 (0) 2 2 (0) 2 (2) 3 6.5 (7.8) 1-21 (8)
Muscle relaxants
(days administered)
Midazolam CRI 6 6.6 (4.9) 2-13 (10) Unknown Unknown Unknown (1) 6.5 6.0 (1.4) 4-7 (4) 6 6.6 (4.9) 2-13 (11)
Diazepam 13 12.1 (10.5) 2-33 (10) 12 13.3 (8.1) 6-22 (3) 2 2 (0) 2 (2) 12 13.3 (11.2) 2-44 (21)
Methocarbamol 23 22.5 (7.0) 14-30 (12) 21.5 21.5 (10.6) 14-29 (2) 3.5 3.5 (3.5) 1-6 (2) 19 20.1 (7.5) 10-30 (17)
Anti-toxin
Dose (IU/kg) 377 410.8 (292.1) 100-1000 (14) 500 416.7 (144.3) 250-500 (4) 100 131.0 (80.1) 71-222 (6) 254 327.3 (256.1) 17-1000 (29)
Days post-onset 3 3.1 (1.7) 1-7 5 4.8 (2.1) 2-7 5 4.1 (1.9) 2-7 4 4.0 (2.0) 1-8
Digit amputation/wound
debridement
Days post-onset 4.5 5.8 (3.1) 4-12 (10) 6.5 6.5 (2.1) 5-8 (2) 7.5 7.5 (0.7) 7-8 (2) 6 6.1 (2.9) 1-12 (18)
Days after wound first
noticed
9.5 11.6 (3.7) 8-15 7.5 7.5 (10.6) 0-15 12 12 (0) 12 12.5 11.9 (6.1) 0-26
Feeding tube
Days in place 18 15 (6.9) 7-26 (15) 7 11.3 (10.2) 4-23 (3) 3.5 4 (2.1) 2-7 (7) 12 14 (7.5) 4-27 (29)
Days placed post-onset 4 5.5 (3.0) 1-12 8 9 (3.6) 6-13 5 4.7 (2.3) 2-8 5 5.7 (2.9) 2-13
Tracheostomy tube
Days in place 17.5 17.5 (0.7) 17-18 (2) 0 0 0 (0) 2.5 2.5 (0.7) 2-3 (3) 12.5 12.3 (6.1) 6-18 (4)
Days placed post-onset 3 3 (0) 3 0 0 0 7 7.0 (2.0) 5-9 3 3.75 (1.5) 3-6
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6 months (2/6; 33%) after onset. Neither frequency nor severity wors-
ened in any dog.
Trial treatment was attempted with antiepileptic medications
(AEDs) in 6/23 dogs. Medications administered included phenobarbi-
tone (n = 5; at 2-3 mg/kg q12h [with 1 dog receiving a loading dose]
for 19-57 days [median and mean of 38 days, SD 26.9]), levetiracetam
(n = 2; at 10-20 mg/kg for 15 days each), and potassium bromide
(n = 1; loading dose then 40 mg/kg/day for 60 days). No perceived
response to AED treatment was noted in any dog.
Based on medical records and completed questionnaires, only
5/50 dogs are known to have not developed cpRBD during their
recovery from tetanus. Because of the low case numbers statistical
evaluation of cpRBD and non-cpRBD cases to determine potential risk
factors was not possible. However, while sex, age, and weight at diag-
nosis were similar between the 2 groups, 5/12 (42%) surviving Labra-
dors and 2/3 (67%) surviving Cocker spaniels developed cpRBD while
neither of these breeds were represented among the dogs known to
have not. The time from identification of a wound/source of infection
to development of clinical signs and from onset of clinical signs to pre-
sentation at a referral center tended to be longer, and duration of hos-
pitalization tended to be shorter, in dogs that did not develop cpRBD
(Table 2). The number of dogs that exhibited progression of their clini-
cal signs during hospitalization was similar between groups (10/23
(44%) dogs with cpRBD versus 2/5 (40%) dogs without reported
cpRBD). Pre-tetanus sleep behavior appeared similar between groups
(Tables 3 and 4), however 3/19 (16%) dogs with post-tetanus cpRBD
were considered by their owners to have overtly “dreamt” more than
other dogs pre-tetanus while no dogs without cpRBD were consid-
ered to have “dreamt” more than other dogs.
4 | DISCUSSION
While abnormal sleep behavior has previously been reported in dogs
recovering from tetanus,5–7 at least 46% of dogs in our study dis-
played episodes consistent with clinically probable RBD, suggesting
this to be a far more prevalent sequel of tetanus than previously
thought. To the authors' knowledge, RBD/cpRBD has not been
reported as a consequence of tetanus in any other species; however,
1 human study reported 6 patients who complained of sleep distur-
bance (difficulty falling asleep, frequent waking during the night and
frequent, terrifying nightmares) after tetanus.12 In these human
patients, there was no history of abnormal sleep patterns before
developing tetanus and the sleep disturbances spontaneously
resolved over a period of approximately 1-3 years. It was not noted
whether dream enactment was present in these patients, contributing
to their frequent waking.
While tetanospasmin toxin is unable to reach the brain via the
bloodstream because of its inability to cross the blood-brain barrier,13
it can reach the brainstem, midbrain, and hypothalamus via retrograde
intraneuronal transport.1 Release of glycine and GABA are prevented,
with experimental studies demonstrating disinhibition of cortical neu-
rons after injection of tetanospasmin into the cerebral cortex, lasting
for over 1 month.14,15
REM sleep is characterized by cortical arousal, pontine-genicu-
late-occipital waves (stimulating brainstem motor centers during
dream activity), and muscle atony. These features are governed by the
pedunculopontine nuclei/laterodorsal tegmental nuclei pathways to
the thalamus, the pontine reticular formation, and the ventromedial
medullary reticular formation.16 The “midbrain extrapyramidal area”
(MEA) has been demonstrated to affect movement in proportion to
behavioral state and the retrorubral and subcuneiformis nuclei appear
to modulate limbic behaviors.16 Development of RBD requires the
loss of REM atony with concurrent disinhibition of the mesencephalic
motor pattern generators.17 Lai and Siegel experimentally demon-
strated in cats that the systems responsible for atonia and locomotion
are colocalized in the pons, providing an anatomical explanation for
their simultaneous dysregulation during RBD.18 Therefore, loss of
inhibition of glutaminergic and cholinergic neurons in the above areas
can result in complex motor behaviors during REM sleep. GABAergic
output from the basal nuclei acts to inhibit the glutamatergic retroru-
bral field and/or MEA neurons that activate the ventromedial medul-
lary zone responsible for maintenance of atonia during REM sleep.16 It
is possible that tetanospasmin binding and its subsequent prevention
of GABA release results in loss of this inhibitory basal nuclei output
and inappropriate activation of motor centers and failure of muscle
atony during REM sleep.
In humans, the International Classification of Sleep Disorders
advised that a diagnosis of RBD requires demonstration of the pres-
ence of REM sleep without atonia on polysomnography, absence of
EEG epileptiform activity during REM sleep, dream enactment behav-
ior and/or abnormal REM sleep behavior documented during
TABLE 2 Comparison of potential clinical severity measures between dogs with and without clinically probable RBD after tetanus
Dogs with cpRBD (n = 23) Dogs without cpRBD (n = 5)
Median Mean (SD) Range Median Mean (SD) Range
Time from identification of wound to onset of clinical signs
(days)
7 6.3 (2.08) 2-10 9 10.3 (4.16) 7-15
Time from onset of clinical signs to presentation (days) 3 4 (2.73) 1-14 7 6.2 (1.64) 4-8
Duration of hospitalization (days) 15 14 (8) 1-30 6 10 (8) 4-23
TABLE 3 Reported “dream” activity before developing tetanus for dogs with and without clinically probable RBD after tetanus
No tendency to dream Twitching Running Vocalization
Dogs with cpRBD (n = 16) 5 (31%) 10 (63%) 5 (31%) 3 (19%)
Dogs without cpRBD (n = 5) 1 (20%) 2 (40%) 2 (40%) 2 (40%)
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polysomnographic recording, and the inability to better explain the
sleep disorder by another disorder or through medication/substance
use.8 Nocturnal epileptic seizure activity manifesting as dream enact-
ment has been described in people, with EEG activity arising from the
REM phase of sleep and the condition proving responsive to adminis-
tration of AEDs.17 Although EEG recordings were not available for
these dogs, the episodes were considered clinically unlikely to be epi-
leptic seizure activity on the basis that these dogs could be easily
woken from the episodes, post-ictal signs were lacking, there were no
autonomic signs and, in dogs where these were trialed, there was no
response to AEDs. Obstructive sleep apnea-induced REM sleep
arousal has also been reported as a cause of immediate dream enact-
ment in humans, after oxygen saturation nadirs of 68%-82%19 and
periods of obstructive apnea lasting up to 51.8  16.5 seconds20 dur-
ing REM sleep. While the oxygen saturation level just before onset of
the abnormal sleep behaviors was unknown in our cases, in dogs for
which video footage or detailed medical records of the episodes wit-
nessed by veterinary staff were available there was no overt ventila-
tory dysfunction or change in respiratory pattern before the episode
onset. Therefore, although a definitive diagnosis of RBD could not be
made in these dogs, the abnormal sleep behavior was considered con-
sistent with clinically probable RBD.
Our study was limited by its retrospective nature and the neces-
sity for questionnaire-based information. Inability to obtain post-
discharge data for all 50 surviving dogs prevented determination of
the prevalence of post-tetanus cpRBD in our study population. It
could be argued that a questionnaire format introduces bias toward
responses from owners of dogs affected by the condition of interest.
However, in our study, questionnaires were not completed by owners
of 3 dogs known to have developed cpRBD based on medical records
(before discharge or post-discharge based on recorded owner
updates) indicating this was not the case. To avoid introducing bias,
the known prevalence of post-tetanus cpRBD in our population was
not calculated based on the total number of returned questionnaires
but on the total number of potential cases.
The retrospective nature of data collection and its reliance on
owner memory will have impacted upon the accuracy of owner-
reported figures regarding time of onset, time to improvement and
even severity of the abnormal dream activity. However, the data
obtained is still pertinent in providing owners of future cases with
guidelines regarding the potential development and expected course
of this condition.
The retrospective nature also prevented utilization of standard-
ized, objective parameters for judgment of clinical severity. The low
number of dogs known to have not developed cpRBD post-tetanus
was also too low to permit statistical evaluation for determination of
significant differences between cpRBD and non-cpRBD dogs and/or
risk factors for the development of cpRBD. However, objective
measures such as a longer time from identification of a wound/source
of infection to development of clinical signs, a longer time from onset
of clinical signs to presentation at a referral center and a shorter dura-
tion of hospitalization, all possibly suggesting a less severe clinical pic-
ture, were noted in dogs that did not develop cpRBD. A more severe
clinical picture in cpRBD dogs was also suggested by the observation
that the administration of a propofol, medetomidine, and/or magne-
sium sulfate CRI was only required in dogs that were known to have
developed cpRBD or to have died. Furthermore, with the exception of
1 non-cpRBD dog, a midazolam CRI and the requirement for an
indwelling urinary catheter were only reported in dogs with cpRBD or
that died. No non-cpRBD dogs required a tracheostomy tube. How-
ever, in 1 dog with post-tetanus cpRBD clinical signs were confined to
the head with no generalization throughout the course of disease.
Further data from cases without cpRBD is necessary to statistically
determine whether clinical severity, as well as breed and characteris-
tics of pre-tetanus sleep behavior, might be risk factors in the devel-
opment of post-tetanus cpRBD.
As reported previously, it is often not possible to isolate C. tetani
from wounds,21 and obvious wounds/sources of infection might not
be evident in all dogs.3–5 Therefore, the diagnosis of tetanus is typi-
cally presumptive, made on the basis of characteristic clinical history,
clinical signs, and their progression, exclusion of other causes of tet-
any and response to treatment. Although a positive clostridial culture
was only achieved in 4/12 (33%) cultures of the suspected infection
source in our study, this is higher than previous canine studies
(0%5-20%4).
The clinical manifestation of RBD/cpRBD shares many character-
istics with epileptic seizure activity, with paddling, twitching, and jaw
chomping arising from a state of rest and potentially an apparently
nonresponsive mental status during the episode. As epileptic seizures
have previously been reported as a consequence of tetanus,3 without
careful questioning of owners/colleagues, attempting to wake the dog
or obtaining an EEG recording there is a great potential for misdiagno-
sis of dogs with post-tetanus cpRBD. Post-tetanus epileptic seizures
have been reported to have the potential to spontaneously resolve
with recovery from tetanus3 and in our study cpRBD resolved within
6 months in 44% of dogs. However, 63% of owners in our study con-
sidered their dogs' episodes moderate or marked in severity. This,
combined with the perceived refractory nature of the episodes with
regards to AED administration, does risk potential euthanasia of mis-
diagnosed dogs. Therefore, owners of dogs affected by tetanus should
be counseled that RBD/cpRBD could develop and, to assist in diagno-
sis, video footage should be obtained, and they should establish
whether they can wake their pet, if safe to do so. As a previous study
has shown a relatively low level of interobserver agreement regarding
classification of paroxysmal events in dogs and cats as epileptic sei-
zures or not on the basis of video footage alone,22 where possible,
TABLE 4 Number of sleep behaviors (twitching, running, and/or vocalization) displayed during “dreaming” before developing tetanus in dogs
with and without clinically probable RBD
1 behavior 2 behaviors 3 behaviors
Dogs with cpRBD (n = 11) 6 (55%) 3 (27%) 2 (18%)
Dogs without cpRBD (n = 4) 1 (20%) 3 (75%) 0 (0%)
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EEG and polysomnography recording should be obtained during an
episode in order to reach a definitive diagnosis.
Interestingly, despite 63% of owners in our study considering
their dog's cpRBD episodes to be moderate or marked in severity, the
dog's quality of life was perceived to be impaired in only 3 dogs (1 min-
imally so [moderate cpRBD severity] and 2 dogs with a mildly
impaired quality of life [moderate and marked cpRBD severity in
1 case each]). Unfortunately, the reasons for the discrepancy in
answers were not explored further. However, both dogs considered
to have mildly impaired quality of life exhibited cpRBD every time
they slept (2/4 dogs with cpRBD every time they slept) and were ini-
tially disorientated/confused when waking (2/5 dogs that were not
immediately normal on waking). This could suggest that a combination
of episode severity, frequency, and behavior on waking could have
contributed to the perceived effect of cpRBD on these dogs. Unfortu-
nately the effect of sleep disturbance on daytime activities was not
explored in this study, and this might also have been a contributing
factor to perceived worsening of quality of life. However, as there
was considered to be no effect of cpRBD on the quality of life of 82%
of affected dogs, it is likely that the cpRBD episodes did not adversely
affect the daytime activities of the majority of dogs in our study.
Onset of cpRBD occurred before discharge in 25% of these cases.
Sleep behavior consistent with cpRBD was noted by owners on the
first day/night of discharge in 44% of the dogs for whom cpRBD was
first reported post-discharge. Despite all dogs being under close
supervision during hospitalization (either 24 hour monitoring by a
staff member physically present in the dog's immediate vicinity or via
a live-feed monitored camera), it is possible that abnormal sleep
behaviors could have been missed by staff. Alternatively, as sleep dis-
ruption is a commonly recognized consequence of hospitalization and
ICU care in humans,23 this close monitoring might have prevented
dogs from reaching an appropriate depth of sleep for an appropriate
duration of time to manifest cpRBD during the hospitalization period.
Our study demonstrates abnormal sleep behaviors, consistent
with clinically probable RBD, is a common sequel to tetanus in dogs.
This condition should be distinguished from epileptic seizure activity
in affected dogs. Although considered by more than half of owners to
be moderate or marked in their severity, these episodes had no per-
ceived effect on the quality of life in the majority of dogs, with the
adverse effect deemed minimal or mild when present. Episodes of
cpRBD typically improved in severity, frequency, or both severity and
frequency with spontaneous resolution in almost half of affected
dogs; therefore, the development of cpRBD should not be considered
to be associated with a negative prognosis. Further studies are neces-
sary to establish risk factors for the development of this condition.
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